UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

Hepatology international, 2021-12, Vol.15 (6), p.1402-1412

2021

Volltextzugriff (PDF)

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Journal of hepatology, 2010-03, Vol.52 (3), p.330-339

2010

Volltextzugriff (PDF)

Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Hepatology international, 2023-08, Vol.17 (4), p.850-859

2023

Volltextzugriff (PDF)

A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus

Molecular therapy. Nucleic acids, 2013, Vol.2 (8), p.e114-e114, Article e114

2013

Volltextzugriff (PDF)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

Hepatology communications, 2022-04, Vol.6 (4), p.841-854

2022

Volltextzugriff (PDF)

Immune Response in Hepatitis B Virus Infection

Cold Spring Harbor perspectives in medicine, 2015-08, Vol.5 (8), p.a021428-a021428

2015

Volltextzugriff (PDF)

273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A298-A298

2020

Volltextzugriff (PDF)

Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

PloS one, 2011-08, Vol.6 (8), p.e23330-e23330

2011

Volltextzugriff (PDF)

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.3177-3188

2017

Volltextzugriff (PDF)

Cancer immunotherapy: Targeting the difference

Journal of hepatology, 2014-11, Vol.61 (5), p.1175-1177

2014

Volltextzugriff (PDF)

T-cell therapy for chronic viral hepatitis

Cytotherapy (Oxford, England), 2017-11, Vol.19 (11), p.1317-1324

2017

Volltextzugriff (PDF)

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

Diseases, 2016-02, Vol.4 (1), p.10

2016

Volltextzugriff (PDF)

Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?

Medical microbiology and immunology, 2015-02, Vol.204 (1), p.87-94

2015

Volltextzugriff (PDF)

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1862-1876.e9

2019

Volltextzugriff (PDF)

Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3

Gastroenterology (New York, N.Y. 1943), 2018-07, Vol.155 (1), p.180-193.e6

2018

Volltextzugriff (PDF)

Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.200-213

2021

Volltextzugriff (PDF)

A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors

JCI insight, 2017-06, Vol.2 (12)

2017

Volltextzugriff (PDF)

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

Journal of hepatology, 2011-07, Vol.55 (1), p.103-110

2011

Volltextzugriff (PDF)

Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells

Nucleic acid therapeutics, 2021-04, Vol.31 (2), p.145-154

2021

Volltextzugriff (PDF)

PS-141-CyTOF-based immune monitoring of HBV-HCC patients receiving autologous anti-tumour T-cell therapy

Journal of hepatology, 2019-04, Vol.70 (1), p.e89-e90

2019

Volltextzugriff (PDF)

Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties

Journal of virology, 2017-05, Vol.91 (9), p.e00010

2017

Volltextzugriff (PDF)

Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

Journal of gastroenterology and hepatology, 2008-06, Vol.23 (6), p.833-843

2008

Volltextzugriff (PDF)

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3

Journal of general virology, 2012-02, Vol.93 (Pt 2), p.247-258

2012

Volltextzugriff (PDF)

Viral hepatitis and serotonin: altering cytotoxic T-lymphocyte function in the liver

Expert review of vaccines, 2009-01, Vol.8 (1), p.29-32

2009

Volltextzugriff (PDF)

Improving on the Ability of Endogenous Hepatitis B Core Antigen to Prime Cytotoxic T Lymphocytes

The Journal of infectious diseases, 2010-06, Vol.201 (12), p.1867-1879

2010

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(24)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(16)
Gastroenterology & Hepatology
(10)
Immunotherapy
(9)
Hepatitis B Virus - Immunology
(8)
Medicin Och Hälsovetenskap
(8)
T Cell Receptors
(8)
Hepatitis B Virus
(7)
Lymphocytes
(7)
Receptors, Antigen, T-Cell - Genetics
(7)
Hepatitis B
(6)
Hepatitis B, Chronic - Immunology
(6)
Lymphocytes T
(6)
Medicine, Research & Experimental
(6)
Patients
(6)
Research & Experimental Medicine
(6)
T-Lymphocytes - Immunology
(6)
Viruses
(6)
Animals
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(4)
Gastroenterology
(2)
Hepatology International
(2)
Cold Spring Harbor Perspectives In Medicine
(1)
Cytotherapy
(1)
Diseases
(1)
Expert Review Of Vaccines
(1)
Hepatology
(1)
Hepatology Communications
(1)
Jci Insight
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC

Immune Response in Hepatitis B Virus Infection

273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation

Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection

Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection

Cancer immunotherapy: Targeting the difference

T-cell therapy for chronic viral hepatitis

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3

Immunosuppressive Drug‐Resistant Armored T‐Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients

A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells

PS-141-CyTOF-based immune monitoring of HBV-HCC patients receiving autologous anti-tumour T-cell therapy

Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties

Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3

Viral hepatitis and serotonin: altering cytotoxic T-lymphocyte function in the liver

Improving on the Ability of Endogenous Hepatitis B Core Antigen to Prime Cytotoxic T Lymphocytes

Aktive Filter

Suchergebnisse filtern